Vascular endothelial growth factor in tear samples of patients with systemic sclerosis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Rentka, Anikó ^a   Hársfalvi, Jolán ^b   Berta, András ^a   Köröskényi, Krisztina ^c   Szekanecz, Zoltán ^a   Szücs, Gabriella ^a   Szodoray, Peter ^d   Kemény Beke, Ádám ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; LACRIMAL FLUID; LACRIMATION; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SAMPLE; SYSTEMIC SCLEROSIS; TEAR FLOW; ADOLESCENT; CHEMISTRY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TEARS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84939616477     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/573681     Document Type: Article

References (19)

1. A. Gabrielli, E. V. Avvedimento, and T. Krieg, Mechanisms of disease: scleroderma, TheNewEngland Journal ofMedicine, vol. 360, no. 19, pp. 1989-2003, 2009.
2. D. Albert and F. A. Jakobiec, Principles and Practice of Ophthalmology, W. B. Saunders Company, Philadelphia, Pa, USA, 5th edition, 2000.
3. S. Plastiras, The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007), The Ocular Surface, vol. 5, no. 2, pp. 75-92, 2007.
4. R.-M. Olander, T. Wuorimaa, H. Kayhty, O. Leroy, R. Dagan, and J. Eskola, Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers, Vaccine, vol. 20, no. 3-4, pp. 336-341, 2001.
5. R. Van Coster, J. Smet, E. George et al., Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects, Pediatric Research, vol. 50, no. 5, pp. 658-665, 2001.
6. S. J. Darmoni, B. Thirion, J. P. Leroy et al., DocCISMEF: a search tool based on encapsulatedMeSH thesaurus, Studies in Health Technology and Informatics, vol. 84, part 1, pp. 314-318, 2001.
7. M. Geyer and U. Muller-Ladner, The pathogenesis of systemic sclerosis revisited, Clinical Reviews in Allergy and Immunology, vol. 40, no. 2, pp. 92-103, 2011.
8. P. Bao, A. Kodra, M. Tomic-Canic, M. S. Golinko, H. P. Ehrlich, and H. Brem, The role of vascular endothelial growth factor in wound healing, Journal of Surgical Research, vol. 153, no. 2, pp. 347-358, 2009.
9. A. M. Byrne, D. J. Bouchier-Hayes, and J. H. Harmey, Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF), Journal of Cellular and Molecular Medicine, vol. 9, no. 4, pp. 777-794, 2005.
10. K. Li, Z. Chen, F. Duan, J. Liang, and K. Wu, Quantification of tear proteins by SDS-PAGE with an internal standard protein: a new method with special reference to small volume tears, Graefes Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 6, pp. 853-862, 2010.
11. E. C. LeRoy and T. A. Medsger Jr., Criteria for the classification of early systemic sclerosis, The Journal of Rheumatology, vol. 28, no. 7, pp. 1573-1576, 2001.
12. A. Masi, Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis and Rheumatology, vol. 23, no. 5, pp. 581-590, 1980.
13. E. Scala, S. Pallotta, A. Frezzolini et al., Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement, Clinical and Experimental Immunology, vol. 138, no. 3, pp. 540-546, 2004.
14. R. Tailor, A. Gupta, A. Herrick, and J. Kwartz, Ocularmanifestations of scleroderma, Survey of Ophthalmology, vol. 54, no. 2, pp. 292-304, 2009.
15. A. Waszczykowska, R. Gós, E. Waszczykowska, B. Dziankowska-Bartkowiak, and P. Jurowski, Prevalence of ocular manifestations in systemic sclerosis patients, Archives of Medical Science, vol. 9, no. 6, pp. 1107-1113, 2013.
16. F. Bock, Y. Konig, T. Dietrich, P. Zimmermann, M. Baier, and C. Cursiefen, Inhibition of angiogenesis in the anterior chamber of the eye, Ophthalmologe, vol. 104, no. 4, pp. 336-344, 2007.
17. J. S. Penn, S. Li, and M. I. Naash, Ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa, Investigative Ophthalmology and Visual Science, vol. 41, no. 12, pp. 4007-4013, 2000.
18. N. Ferrara and W. J. Henzel, Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells, Biochemical and Biophysical Research Communications, vol. 161, no. 2, pp. 851-858, 1989.
19. M. Vesaluoma, A. M. Teppo, C. Gronhagen-Riska, and T. Tervo, Release of TGF-beta1 and VEGF in tears following photorefractive keratectomy, Current Eye Research, vol. 16, no. 1, pp. 19-25, 1997.